Lee DH - Search Results

1

A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors.

Cho BC, Han JY, Kim SW, Lee KH, Cho EK, Lee YG, Kim DW, Kim JH, Lee GW, Lee JS, Shim BY, Kim JS, Chun SH, Lee SS, Kim HR, Hong MH, Ahn JS, Sun JM, Lee Y, Lee DH, Kang JA, Lee N, Kwon MJ, Espenschied C, Yablonovitch A, Ahn MJ. Cho BC, et al. Among authors: lee dh, lee js, lee y, lee kh, lee yg, lee n, lee gw, lee ss. J Thorac Oncol. 2022 Apr;17(4):558-567. doi: 10.1016/j.jtho.2021.11.025. Epub 2021 Dec 24. J Thorac Oncol. 2022. PMID: 34958928 Free article. Clinical Trial.

2

Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers.

Lee DH, Han JY, Lee HG, Lee JJ, Lee EK, Kim HY, Kim HK, Hong EK, Lee JS. Lee DH, et al. Among authors: lee ek, lee js, lee hg, lee jj. Clin Cancer Res. 2005 Apr 15;11(8):3032-7. doi: 10.1158/1078-0432.CCR-04-2149. Clin Cancer Res. 2005. PMID: 15837758 Clinical Trial.

3

Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.

Han JY, Cho KH, Lee DH, Kim HY, Kim EA, Lee SY, Lee JS. Han JY, et al. Among authors: lee dh, lee sy, lee js. J Clin Oncol. 2005 May 20;23(15):3488-94. doi: 10.1200/JCO.2005.01.082. J Clin Oncol. 2005. PMID: 15908658 Clinical Trial.

4

Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.

Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS. Lee DH, et al. Among authors: lee js. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1037-44. doi: 10.1016/j.ijrobp.2005.04.034. Epub 2005 Jul 18. Int J Radiat Oncol Biol Phys. 2005. PMID: 16024178 Clinical Trial.

5

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer.

Han JY, Lee DH, Lee SY, Park CG, Kim HY, Kim EA, Yoon SM, Lee HG, Lee JS. Han JY, et al. Among authors: lee dh, lee sy, lee js, lee hg. Med Oncol. 2005;22(3):281-90. doi: 10.1385/MO:22:3:281. Med Oncol. 2005. PMID: 16110139 Clinical Trial.

6

Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma.

Han JY, Lee DH, Lee SY, Park CG, Kim HY, Lee HG, Lee JJ, Kim HT, Lee JS. Han JY, et al. Among authors: lee dh, lee sy, lee js, lee hg, lee jj. Cancer. 2005 Dec 15;104(12):2759-65. doi: 10.1002/cncr.21563. Cancer. 2005. PMID: 16294344 Free article. Clinical Trial.

7

Randomized Phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinoma.

Han JY, Lim HS, Lee DH, Ju SY, Lee SY, Kim HY, Park YH, Park CG, Lee JS. Han JY, et al. Among authors: lee dh, lee sy, lee js. Cancer. 2006 Feb 15;106(4):873-80. doi: 10.1002/cncr.21668. Cancer. 2006. PMID: 16411223 Free article. Clinical Trial.

8

A pilot trial of gemcitabine and vinorelbine plus capecitabine in locally advanced or metastatic nonsmall cell lung cancer.

Lee DH, Han JY, Yoon SM, Lee JJ, Lee HG, Kim HY, Yoon SJ, Hong EK, Lee JS. Lee DH, et al. Among authors: lee js, lee hg, lee jj. Am J Clin Oncol. 2006 Apr;29(2):143-7. doi: 10.1097/01.coc.0000203743.32845.40. Am J Clin Oncol. 2006. PMID: 16601432 Clinical Trial.

9

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.

Han JY, Lim HS, Shin ES, Yoo YK, Park YH, Lee JE, Jang IJ, Lee DH, Lee JS. Han JY, et al. Among authors: lee dh, lee js, lee je. J Clin Oncol. 2006 May 20;24(15):2237-44. doi: 10.1200/JCO.2005.03.0239. Epub 2006 Apr 24. J Clin Oncol. 2006. PMID: 16636344

10

Gefitinib is of more benefit in chemotherapy-naive patients with good performance status and adenocarcinoma histology: retrospective analysis of 575 Korean patients.

Lee DH, Han JY, Kim HT, Lee JS. Lee DH, et al. Among authors: lee js. Lung Cancer. 2006 Sep;53(3):339-45. doi: 10.1016/j.lungcan.2006.05.015. Epub 2006 Jul 5. Lung Cancer. 2006. PMID: 16824646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,774 results

Search Page